Announcement, From Bench to Fireside 02.22.24 Share on Twitter Share on Facebook Share on LinkedIn From Synthetic Biology to Emerging Technologies with Justin Eyquem, PhD In this episode, Justin Eyquem, PhD, Parker Senior Fellow and PICI Member Researcher at the University of California, San Francisco, talks about his visionary work pioneering CAR-T cell therapies and synthetic biology with PICI Chief Scientific Officer John Connolly, PhD. Listen as Justin provides an inside look at the CAR-T revolution, from next-generation therapies to cutting-edge advancements like in vivo delivery and AI-powered design. Hear him discuss his journey from bioengineering student to gene-editing innovator with support from PICI’s collaborative network of experts and resources. Get ready to go from bench to fireside with Justin Eyquem, PhD. Listen on Spotify Related Announcement PICI Hosts 2024 Spring Scientific Retreat Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes Announcement, From Bench to Fireside Episode Nine: Katie Campbell, PhD
Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes